🚨Today's Scientific Gastroenterological Colloquium @MHH:

💡Relevance of hepatopulmonary syndrome,
intrapulmonary vascular dilatations &
residual minimal #ascites in the setting of #TIPS

Tune in for this online lecture by Jim Mauz:
📺 today, 5pm: bit.ly/3YLcq2l

#liversky #cirrhosis #medsky

🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter (PeCa), or ascites pump?

🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis & device explantations 📈

👥 Sarah Schütte et al in Hepatology Communications
🔗 bit.ly/42k8too

#liversky #medsky #cirrhosis

🆕 TIPS insertion leads to sustained reversal of systemic inflammation in patients with decompensated liver #cirrhosis

💡decrease of 25 SIMs, CRP, sCD14
💡CRP📉=survival📈
💡interplay between ascites control & SI

👥Tiede & Stockhoff et al in Clinical and Molecular Hepatology
🔗 bit.ly/40zGD6q

#liversky

🆕 Value of systemic inflammation markers for the detection of minimal & prediction of overt #HE after #TIPS

🔎 IL-6, IL-1ß, TNF-α
❌ no correlation with mHE & tests
❌ prediction post-TIPS oHE

👥 A.Tiede et al in Metabolic Brain Disease
🔗 bit.ly/49CM3jY

#liversky #cirrhosis

🆕 Identification of optimal portal pressure decrease to control #ascites while minimizing HE after #TIPS: A multicenter study

❓What's the "sweet spot" of PPG reduction?
💡 60-80% ⬇️ = reduced ascites w/o increased oHE risk!

👥 M. Kabelitz et al in Hepatology
🔗 bit.ly/4fYNIlE

#liversky #cirrhosis

Wrapping up a year that was as hepatic as it was fantastic! 🎄
Celebrating a year full of progress, teamwork, fun, and plenty of discoveries. Grateful for this team and looking forward to what 2025 has in store for us.

🎅 Happy Holidays from our lab to yours! ❄️🎁
#liversky #hepsky #medsky